This comes as the medical school breaks its previous record for NIH research funding, with more than $200 million in grants.
“Yet again, the UC Davis School of Medicine’s extraordinary research teams have achieved record high NIH funding and increased our school’s national ranking,” said Susan Murin, interim dean of the UC Davis School of Medicine. “We are grateful to our pioneering researchers across all disciplines who are discovering pathways to new treatments and cures and helping us deliver tomorrow’s health care today.”
UC Davis School of Medicine Departments in the Top 20
This year, nine School of Medicine departments ranked in the top 20 nationally in their respective fields. They included:
Sergey Stavisky, assistant professor in the Department of Neurological Surgery, won an NIH grant to understand and restore speech production using an intracortical brain-computer interface.
Thanks to the NIH funds, UC Davis researchers are designing and testing therapies for many diseases for patients across different age groups. These include both common and rare conditions. The grants fuel cutting-edge research, such as learning about autism changes over time, developing new ways to diagnose and treat different types of cancers, and studying dementia in people aged 90 and above.
“Research funding translates into tomorrow’s discoveries, insight and products that can offer a brighter future for our local and global community,” said Kim E. Barrett, vice dean for research and distinguished professor of physiology and membrane biology. “We are proud of our research programs that address a diverse range of health and medical needs, often bringing together experts across disciplines to collaborate on groundbreaking discoveries.”
Rachel Whitmer, associate director of the Alzheimer’s Disease Research Center, is the principal investigator on a $25 million NIH grant to study brain health and dementia.
The current development of Aggie Square is expected to double the school’s research space and provide additional resources to its research community. “Aggie Square will further advance the School of Medicine’s trajectory of increased funding and national leadership,” Murin noted.
